Toxta 100 Units is the original strain sourced from the European National Institute, offering a high-purity product with a low risk of immunogenicity. It adheres to cGMP standards set by regulatory bodies such as the FDA and EMA, ensuring a safe and swift solution for wrinkle improvement and the treatment of larger muscles.
Key features of Toxta 100 units include: improvement of mimic wrinkles, correction of lip contour, high purity level (99.8%), KFDA approval, fast and long-lasting results.
Manufactured using the original botulinum toxin strain from the European National Institute, Toxta 100 Units is cGMP compliant, presenting a low risk of immune resistance development due to its minimal protein content. This underscores its commitment to providing a safe and effective option for patients seeking wrinkle improvement and muscle treatment.